---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-21-000913"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T10:37:04.063345+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Electromed Q1 FY2022 revenue hits record $10.0M, up 25% YoY; EPS $0.05 vs $0.06

## Summary
- Net revenue $10.0M, record quarterly; home care up 24.4% to $9.3M, institutional up 61.5% to $449K.
- Net income $439K ($0.05 diluted EPS) vs $535K ($0.06) prior year; operating income $538K vs $663K.
- Gross margin 77.0% vs 76.8%; SG&A rose to 67.9% of revenue due to strategic investments and shareholder activism costs.
- Cash $11.0M, no debt; field sales employees 51 (41 direct reps), with record annualized home care revenue per rep of $955K.
- Next-gen airway clearance device expected to launch in first half of FY2023 after FDA 510(k) clearance.

## SEC filing metadata
- accession: 0000897101-21-000913
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710121000913/0000897101-21-000913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710121000913/elmd211375_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-21-000913
- JSON: https://secwatch.observer/filing/0000897101-21-000913.json
- Plain text: https://secwatch.observer/filing/0000897101-21-000913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.